What I have tried to get longs to do for years. Some intelligent longs follow this practice. Others don't. I guess they just like to argue/debate.
I've got better things to do.
Market opportunities (i.e. profits) for drug development are much greater. That's why Keith did the latest shelf. For the potential opportunity to enter that area in whole or in part with some other pharma.
Makes perfect sense for shareholders.
March 9th at the latest. Earlier (like March 2nd) would be great.
I'm glad I waited to buy more. Sorry, rappy. I've been in your shoes many times. But it will be a fleeting bad memory if Murphy and company deliver.
I expected to see an announcement of a secondary this morning given yesterday's letter to shareholders. I was happy not to see it today, but instead the announcement of the March 5th investor conference/report.
This makes me hopeful that the additional financing will be funded through a targeted institutional investor(s) (something like ADXS's recent secondary which had a beneficial effect of the pps) or through one of ONVO's partners like Jannsen as reilly mentioned. Which would have a beneficial effect as well.
And the "game" continues till we hear substantive news.
I'm kicking myself because I was too greedy, and was hoping (in a perverse way, mind you) that the pps would drop to 5.75. Had a buy order in at that level.
No matter. I'm glad the price is heading up again. A yo-yo cycle that will finally be broken sometime within the first half of 2015.
RIGL is going to start moving upwards again after expected profit taking and consolidation.
I've got funds ready to increase my position at the ready. I welcome the pullback.
I think you're right, reilly. NASDAQ has the most up-to-date numbers of the two.